BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30773131)

  • 1. Elastin-Like Polypeptide Delivers a Notch Inhibitory Peptide to Inhibit Tumor Growth in Combination with Paclitaxel.
    Ryu JS; Robinson L; Raucher D
    J Chemother; 2019 Feb; 31(1):23-29. PubMed ID: 30773131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells.
    Opačak-Bernardi T; Ryu JS; Raucher D
    J Drug Target; 2017 Jul; 25(6):523-531. PubMed ID: 28140690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity.
    Dragojevic S; Ryu JS; Hall ME; Raucher D
    Molecules; 2022 May; 27(11):. PubMed ID: 35684309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
    Walker L; Perkins E; Kratz F; Raucher D
    Int J Pharm; 2012 Oct; 436(1-2):825-32. PubMed ID: 22850291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.
    Ryu JS; Raucher D
    Expert Opin Drug Deliv; 2015 Apr; 12(4):653-67. PubMed ID: 25350837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.
    Hearst SM; Walker LR; Shao Q; Lopez M; Raucher D; Vig PJ
    Neuroscience; 2011 Dec; 197():369-80. PubMed ID: 21958864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.
    Bidwell GL; Raucher D
    Mol Cancer Ther; 2005 Jul; 4(7):1076-85. PubMed ID: 16020665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design and delivery of a PKA inhibitory polypeptide to treat SCA1.
    Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ
    J Neurochem; 2014 Oct; 131(1):101-14. PubMed ID: 24903464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
    Meyer DE; Kong GA; Dewhirst MW; Zalutsky MR; Chilkoti A
    Cancer Res; 2001 Feb; 61(4):1548-54. PubMed ID: 11245464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine.
    Ryu JS; Raucher D
    Cancer Lett; 2014 Jun; 348(1-2):177-84. PubMed ID: 24680816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.
    Moktan S; Raucher D
    Int J Pept Res Ther; 2012 Sep; 18(3):227-237. PubMed ID: 23105921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
    Bidwell GL; Davis AN; Raucher D
    J Control Release; 2009 Apr; 135(1):2-10. PubMed ID: 19095020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastin-like polypeptides: the influence of its molecular weight on local hyperthermia-induced tumor accumulation.
    Ryu JS; Raucher D
    Eur J Pharm Biopharm; 2014 Oct; 88(2):382-9. PubMed ID: 24866938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.
    Moktan S; Perkins E; Kratz F; Raucher D
    Mol Cancer Ther; 2012 Jul; 11(7):1547-56. PubMed ID: 22532601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer.
    Walker LR; Ryu JS; Perkins E; McNally LR; Raucher D
    Drug Des Devel Ther; 2014; 8():1649-58. PubMed ID: 25336913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia.
    Eddy AC; Howell JA; Chapman H; Taylor E; Mahdi F; George EM; Bidwell GL
    Hypertension; 2020 Jan; 75(1):193-201. PubMed ID: 31786977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent Targeting Based Delivery of Therapeutic Peptide using AP1-ELP Carrier for Effective Cancer Therapy.
    Sarangthem V; Kim Y; Singh TD; Seo BY; Cheon SH; Lee YJ; Lee BH; Park RW
    Theranostics; 2016; 6(12):2235-2249. PubMed ID: 27924160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model.
    Bidwell GL; Perkins E; Hughes J; Khan M; James JR; Raucher D
    PLoS One; 2013; 8(1):e55104. PubMed ID: 23372821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth.
    Bidwell GL; Perkins E; Raucher D
    Cancer Lett; 2012 Jun; 319(2):136-143. PubMed ID: 22261328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.